475 related articles for article (PubMed ID: 33940011)
1. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.
Schlag AK; O'Sullivan SE; Zafar RR; Nutt DJ
Neuropharmacology; 2021 Jun; 191():108586. PubMed ID: 33940011
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
3. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
4. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
Sakal C; Lynskey M; Schlag AK; Nutt DJ
Psychopharmacology (Berl); 2022 May; 239(5):1147-1155. PubMed ID: 33970291
[TBL] [Abstract][Full Text] [Related]
5. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids in treatment-resistant epilepsy: A review.
O'Connell BK; Gloss D; Devinsky O
Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
[TBL] [Abstract][Full Text] [Related]
7. Real World Evidence in Medical Cannabis Research.
Banerjee R; Erridge S; Salazar O; Mangal N; Couch D; Pacchetti B; Sodergren MH
Ther Innov Regul Sci; 2022 Jan; 56(1):8-14. PubMed ID: 34748204
[TBL] [Abstract][Full Text] [Related]
8. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023.
Lewis M; Baroutian S; Hanning SM
Curr Pain Headache Rep; 2024 Mar; 28(3):109-118. PubMed ID: 38095748
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA; Raup-Konsavage WM; Vrana KE
Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Allendorfer JB; Szaflarski JP
Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
[TBL] [Abstract][Full Text] [Related]
11. The value of real world evidence: The case of medical cannabis.
Schlag AK; Zafar RR; Lynskey MT; Athanasiou-Fragkouli A; Phillips LD; Nutt DJ
Front Psychiatry; 2022; 13():1027159. PubMed ID: 36405915
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP
Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
[TBL] [Abstract][Full Text] [Related]
14. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
Friedman D; Sirven JI
Epilepsy Behav; 2017 May; 70(Pt B):298-301. PubMed ID: 28089286
[TBL] [Abstract][Full Text] [Related]
15. Clinical uses of cannabis and cannabinoids in the United States.
Levinsohn EA; Hill KP
J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of cannabidiol trials in neurodevelopmental disorders.
Parrella NF; Hill AT; Enticott PG; Barhoun P; Bower IS; Ford TC
Pharmacol Biochem Behav; 2023 Sep; 230():173607. PubMed ID: 37543051
[TBL] [Abstract][Full Text] [Related]
17. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S
Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160
[TBL] [Abstract][Full Text] [Related]
18. Medicinal cannabis for the treatment of anxiety disorders.
Berger M; Amminger GP; McGregor IS
Aust J Gen Pract; 2022 Aug; 51(8):586-592. PubMed ID: 35908759
[TBL] [Abstract][Full Text] [Related]
19. Dark Classics in Chemical Neuroscience: Δ
Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Morini L; Porro G; Liso M; Groppi A
Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
